In a new study led by Yale Cancer Center, researchers have discovered a novel metabolic gatekeeper mechanism for leukemia. This mechanism depends on a molecule called PON2, which could lead to a new treatment for the disease. ...
Feb 1, 2021
0
64
Errors in the way chromosomes are packed into antibody-producing B cells appear to play a role in the development of B cell-related blood cancers, according to a new study by researchers at Columbia University Vagelos College ...
Feb 1, 2021
0
42
With the U.S. facing vaccination delays because of worker shortages and distribution problems, federal health officials now say it's OK to push back the second dose of the two-part vaccine by as much as six weeks.
Jan 28, 2021
0
11
Millions of people across the world have been infected with SARS-CoV-2, the virus that causes COVID-19. Countries are also now embarking on massive vaccination campaigns to control the virus and protect their most vulnerable ...
Jan 12, 2021
0
8
MDC researchers have developed a new approach to CAR T-cell therapy. The team has shown in Nature Communications that the procedure is very effective, especially when it comes to fighting follicular lymphomas and chronic ...
Jan 11, 2021
0
11
New data suggest that nearly all COVID-19 survivors have the immune cells necessary to fight re-infection.
Jan 6, 2021
0
538
A research study at the University of Chicago has found that in pregnancy, while the T cell response to a fetus becomes tolerant to allow for successful pregnancy, the part of the immune system that produces antibodies (known ...
Jan 4, 2021
0
11
Australian researchers have revealed—for the first time—that people who have been infected with the COVID-19 virus have immune memory to protect against reinfection for at least eight months.
Dec 22, 2020
3
3081
A drug widely used to treat fungal infections improved key biomarkers in lung tissue cultures as well as in the noses of patients with cystic fibrosis, a clinical study by researchers at the University of Illinois Urbana-Champaign ...
Dec 17, 2020
0
1
Scientists at Scripps Research have demonstrated a promising new strategy for treating lymphomas, a group of cancers that begin in infection-fighting cells of the immune system called lymphocytes.
Dec 16, 2020
0
73
